Atlas Trials

A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome

Clinical trial NCT04141969 · COMPLETED

Trial details

NCT number
NCT04141969
Sponsor
Optimal Health Research
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Post-Lyme Disease Syndrome (PLDS)
Start date
2019-11-29
Primary completion
2020-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.